Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.705
+0.145 (4.07%)
At close: Aug 17, 2026, 4:00 PM EDT
3.770
+0.065 (1.75%)
After-hours: Aug 17, 2026, 7:55 PM EDT
Zentalis Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
106
Market Cap
265.54M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 67.43M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 175.14M |
| Orchestra BioMed Holdings | 31.98M |
| AC Immune | 21.67M |
| ProQR Therapeutics | 21.05M |
| Lineage Cell Therapeutics | 13.08M |
| Pyxis Oncology | 11.04M |
| Adagene | 9.29M |
| Whitehawk Therapeutics | 7.15M |
ZNTL News
- 7 hours ago - Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 1 day ago - Zentalis announecs common stock offering, no amount given - TheFly
- 4 days ago - Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering - GlobeNewsWire
- 4 days ago - Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering - GlobeNewsWire
- 10 days ago - Zentalis price target raised to $5 from $4 at Morgan Stanley - TheFly
- 11 days ago - Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 11 days ago - Zentalis Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 11 days ago - Zentalis Pharmaceuticals Earnings release: Q2 2026 - Filings